A new facet of ADP-ribosylation reactions: SIRTs and PARPs interplay

Frontiers in Bioscience - Landmark

Volumn 20, Issue 3, 2015, Pages 458-473

  Mennella, Maria Rosaria Faraone ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

Author keywords

ADPRibosylation; NAD; Poly ADP ribose; Poly ADP ribose polymerase; Sirtuin

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SIRTUIN;

ADENOSINE DIPHOSPHATE RIBOSE; POLY(ADP-RIBOSE) POLYMERASES; SIRTUINS;

EID: 84918492954     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4319     Document Type: Review

References (123)

1. Dólle C, R H Skoge, M R Vanlinden, M Ziegler: NAD Biosynthesis In Humans - Enzymes, Metabolites And Therapeutic Aspects. Curr Top Med Chem, 13(23), 2907-2917 (2013)
2. Koch-Nolte F, S Fischer, F Haag, M Ziegler: Compartmentation of NAD+- dependent signalling. FEBS Lett, 585, 1651-1656 (2011) DOI: 10.1016/j.febslet.2011.03.045
3. Oka S, C P Hsu, J Sadoshima: Regulation of cell survival and death by pyridine nucleotides. Circ Res, 111(5), 611-627 (2012) DOI: 10.1161/CIRCRESAHA.111.247932
4. Mouchiroud L, R H Houtkooper, J Auwerx: NAD+ metabolism: A therapeutic target for age-related metabolic disease. Crit Rev Biochem Mol Biol, 48(4), 397-408 (2013) DOI: 10.3109/10409238.2013.789479
5. Dólle C, J G M Rack, M Ziegler: NAD and ADP-ribose metabolism in mitochondria. FEBS Journal, 280 (15), 3530-3541 (2013) DOI: 10.1111/febs.12304
6. Feijs K L, P Verheugd, B Lüscher: Expanding functions of intracellular resident mono-ADP-ribosylation in cell physiology. FEBS J, 280(15), 3519-3529 (2013) DOI: 10.1111/febs.12315
7. Dani N, A Stilla, D Corda, M Di Girolamo: Physiological relevance of the endogenous mono(ADP-ribosyl)ation of cellular proteins. Curr Top Med Chem., 13(23), 3001-3010 (2013)
8. Hassa P O, M O Hottiger: The diverse biological roles of mammalian PARPs, a small but powerful family of poly-ADPribose polymerases. Front Biosci, 13, 3046-3082 (2008) DOI: 10.2741/2909
9. Ferrero E, N Lo Buono, A L Horenstein, A Funaro, F Malavasi: The ADP-ribosyl cyclases - the current evolutionary state of the ARCs. Front Biosci (Landmark Ed), 19, 986-1002 (2014) DOI: 10.2741/4262
10. Nakagawa T, L Guarente: Sirtuins at a glance. J Cell Sci, 124, 833-838 (2011) DOI: 10.1242/jcs.081067
11. Zou L, J Chatham: Nicotinamide adenine dinucleotide hydrate regulates glucose deprivation-induced activation of protein O-GlcNAcylation, ER stress and autophagy. FASEB J, 28 (1), S.1154.2. (2010)
12. Massudi H, R Grant, N Braidy, J Guest, B Farnsworth, G J Guillemin: Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One, 7(7), e42357 (2012) DOI: 10.1371/journal.pone.0042357
13. Braidy N, A Poljak, R Grant, T Jayasena, H Mansour, T Chan-Ling, G J Guillemin, G Smythe, P Sachdev: Mapping NAD(+) metabolism in the brain of ageing Wistar rats: potential targets for influencing brain senescence. Biogerontology, 15(2), 177-198 (2014) DOI: 10.1007/s10522-013-9489-5
14. Chiarugi A, C Dólle, R Felici, M Ziegler: The NAD metabolome-a key determinant of cancer cell biology. Nat Rev Cancer, 12(11), 741-752 (2012) DOI: 10.1038/nrc3340
15. Jessica L, E Feldman, K Dittenhafer-Reed, M J Denu: Sirtuin Catalysis and Regulation. J Biol Chem, 276 (51), 42419-42427 (2012)
16. Denu J M, J M Gottesfeld: Sirtuins: From Biochemistry to Health and Disease J Biol Chem, 287, 42417-42418 (2012) DOI: 10.1074/jbc.R112.428862
17. Schreiber V, F Dantzer, J C Amè, G de Murcia: Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol, 7(7), 517-528 (2006) DOI: 10.1038/nrm1963
18. Thomas C, A V Tulin: Poly-ADP-ribose polymerase: machinery for nuclear processes. Mol Aspects Med, 34(6), 1124-37 (2013) DOI: 10.1016/j.mam.2013.04.001
19. Bürkle A, L Virág: Poly(ADP-ribose): PARadigms and PARadoxes. Mol Aspects Med, 34(6), 1046-1065 (2013) DOI: 10.1016/j.mam.2012.12.010
20. Abd Elmageed Z Y, A S Naura, Y Errami, M Zerfaoui: The poly(ADPribose) polymerases (PARPs): new roles in intracellular transport. Cell Signal, 24(1),1-8 (2012) DOI: 10.1016/j.cellsig.2011.07.019
21. Min W, Z Q Wang: Poly (ADP-ribose) glycohydrolase (PARG) and its therapeutic potential. Front Biosci (Landmark Ed), 14,1619-1626 (2009) DOI: 10.2741/3329
22. Oka S, J Kato, J Moss: Identification and characterization of a mammalian 39-kDa poly(ADP-ribose) glycohydrolase. J Biol Chem, 281(2), 705-713 (2006) DOI: 10.1074/jbc.M510290200
23. Mashimo M, J Kato, J Moss: Structure and function of the ARH family of ADP-ribosyl-acceptor hydrolases. DNA Repair (Amst), S1568-7864(14)00076-7 (2014)
24. Luna A, M I Aladjem, K W Kohn: SIRT1/PARP1 crosstalk: connecting DNA damage and metabolism Genome Integrity, 4, 6 (2013)
25. Bai P, C Cantó, H Oudart, A Brunyánszki, Y Cen, C Thomas, H Yamamoto, A Huber, B Kiss, R H Houtkooper, K Schoonjans, V Schreiber, A A Sauve, J Menissier-de Murcia, J Auwerx: PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab, 13(4), 461-468 (2011) DOI: 10.1016/j.cmet.2011.03.004
26. Frye R A: Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys Res Commun 273, 793-798 (2000) DOI: 10.1006/bbrc.2000.3000
27. Brachmann C B, J M Sherman, S E Devine, E E Cameron, L Pillus, J D Boeke: The SIR2 gene family, conserved from bacteria to humans, functions in silencing, cell cycle progression, and chromosome stability. Genes & Dev. 9, 2888-2890 (1995). DOI: 10.1101/gad.9.23.2888
28. Guarente L: Sir2 links chromatin silencing, metabolism, and aging. Genes & Dev, 14, 1021-1026 (2000)
29. Sauve A A, C Wolberger, V L Schramm. J D Boeke: The biochemistry of sirtuins. Annu Rev Biochem, 75, 435-465 (2006) DOI: 10.1146/annurev.biochem.74.082803.133500
30. Dali-Youcef N, M Lagouge, S Froelich, C Koehl, K Schoonjans, aJ Auwerx: Sirtuins: the 'magnificent seven', function, metabolism and longevity. Ann Med 39, 335-345 (2007) DOI: 10.1080/07853890701408194
31. Landry J, A Sutton, S T Tafrov, R C Heller, J Stebbins, L Pillus, R Sternglanz: The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc Natl Acad Sci 97, 5807-5811 (2000) DOI: 10.1073/pnas.110148297
32. Grubisha O, L A Rafty, C L Takanishi, X Xu, L Tong, A L Perraud, A M Scharenberg, J M Denu: Metabolite of SIR2 reaction modulates TRPM2 ion channel. J Biol Chem 281,14057-14065 (2006) DOI: 10.1074/jbc.M513741200
33. Tanner K G, J Landry, R Sternglanz, J M Denu: Silent information regulator 2 family of NAD- dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proc Natl Acad Sci USA, 97, 14178-14182 (2000) DOI: 10.1073/pnas.250422697
34. Langley E, M Pearson, M Faretta, U M Bauer, R A Frye, S Minucci, P G Pelicci, T Kouzarides: Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J, 21(10), 2383-2396 (2002) DOI: 10.1093/emboj/21.10.2383
35. Li X, N Kazgan: Mammalian Sirtuins and Energy Metabolism Int J Biol Sci 7(5), 575-587 (2011)
36. Imai S I, L Guarente: NAD+ and sirtuins in aging and disease. Trends Cell Biol, pii: S0962-8924(14)00063-4. DOI: 10.1.016/j.tcb.2014.0.4.0.02 (2014)
37. Hall J A, J E Dominy, Y Lee, P Puigserver: The sirtuin family's role in aging and ageassociated pathologies. J Clin Invest, 123(3), 973-979 (2013) DOI: 10.1172/JCI64094
38. Chalkiadaki A, L Guarente: Sirtuins mediate mammalian metabolic responses to nutrient availability. Nat Rev Endocrinol, 8(5), 287-296 (2012) DOI: 10.1038/nrendo.2011.225
39. Curtis J, R de Cabo: Utilizing calorie restriction to evaluate the role of sirtuins in healthspan and lifespan of mice. Methods Mol Biol, 1077, 303-311 (2013) DOI: 10.1007/978-1-62703-637-5-20
40. Guarente L: Calorie restriction and sirtuins revisited.Genes Dev, 27(19), 2072-2085 (2013) DOI: 10.1101/gad.227439.113
41. Chang H C, L Guarente: SIRT1 and other sirtuins in metabolism. Trends Endocrinol Metab, 25(3), 138-145 (2014) DOI: 10.1016/j.tem.2013.12.001
42. Wu Y T, S B Wu, Y H Wei: Roles of Sirtuins in the Regulation of Antioxidant Defense and Bioenergetic Function of Mitochondria under Oxidative Stress. Free Radic Res, 2014 May 6. PMID:24797412
43. Cheng Y, H Takeuchi, Y Sonobe, S Jin, Y Wang, H Horiuchi, B Parajuli, J Kawanokuchi, T Mizuno, A Suzumura: Sirtuin 1 attenuates oxidative stress via upregulation of superoxide dismutase 2 and catalase in astrocytes. Neuroimmunol, 269(1-2), 38-43 (2014) DOI: 10.1016/j.jneuroim.2014.02.001
44. Shao D, J L Fry, J Han, X Hou, D R Pimentel, R Matsui, R A Cohen, M M Bachschmid: A redox-resistant sirtuin-1 mutant protects against hepatic metabolic and oxidant stress. J Biol Chem, 289(11), 7293-7306 (2014) DOI: 10.1074/jbc.M113.520403
45. Rodgers J T, C Lerin, W Haas, S P Gygi, B M Spiegelman, P Puigserver : Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature, 434(7029), 113-118 (2005) DOI: 10.1038/nature03354
46. Gerhart-Hines Z, J T Rodgers, O Bare, C Lerin, S H Kim, R Mostoslavsky, F W Alt, Z Wu, P Puigserver: Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J, 26(7),1913-1923 (2007) DOI: 10.1038/sj.emboj.7601633
47. Brunet A, L B Sweeney, J F Sturgill, K F Chua, P L Greer, Y Lin, H Tran, S E Ross, R Mostoslavsky, H Y Cohen, L S Hu, H L Cheng, M P Jedrychowski, S P Gygi, D A Sinclair, F W Alt, M E Greenberg: Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase.Science, 303(5666), 2011-2015 (2004) DOI: 10.1126/science.1094637
48. Giannakou M E, L Partridge: The interaction between FOXO and SIRT1: tipping the balance towards survival. Trends Cell Biol, 14(8), 408-412 (2004) DOI: 10.1016/j.tcb.2004.07.006
49. Purushotham A, T T Schug, X Li: SIRT1 performs a balancing act on the tight-rope toward longevity. Aging (Albany NY), 1(7), 669-673 (2009)
50. Feige J N, M Lagouge, C Canto, A Strehle, S M Houten, J C Milne, P D Lambert, C Mataki, P J Elliott, J Auwerx: Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab, 8(5), 347-58 (2008). Erratum in: Cell Metab, 9(2), 210 (2009) DOI: 10.1016/j.cmet.2008.08.017
51. Fulco M, V Sartorelli: Comparing and contrasting the roles of AMPK and SIRT1 in metabolic tissues. Cell Cycle, 7(23), 3669-3679 (2008) DOI: 10.4161/cc.7.23.7164
52. Cantó C, J Auwerx: AMP-activated protein kinase and its downstream transcriptional pathways. Cell Mol Life Sci, 67(20), 3407-3423 (2010) DOI: 10.1007/s00018-010-0454-z
53. Lan F, J M Cacicedo, N Ruderman, Y Ido: SIRT1 Modulation of the Acetylation Status, Cytosolic Localization, and Activity of LKB1. POSSIBLE ROLE IN AMP-ACTIVATED PROTEIN KINASE ACTIVATION. J Biol Chem, 283, 27628-27635 (2008) DOI: 10.1074/jbc.M805711200
54. Pillai V B, N R Sundaresan, G Kim, M Gupta, S B Rajamohan, J B Pillai, S Samant, P V Ravindra, A Isbatan, M P Gupta: Exogenous NAD Blocks Cardiac Hypertrophic Response via Activation of the SIRT3-LKB1-AMP-activated Kinase Pathway. J Biol Chem, 285, 3133-3144 (2010) DOI: 10.1074/jbc.M109.077271
55. Liu T F, V T Vachharajani, B K Yoza, C E McCall: NAD+-dependent sirtuin 1 and 6 proteins coordinate a switch from glucose to fatty acid oxidation during the acute inflammatory response. J Biol Chem, 287(31), 25758-25769 (2012) DOI: 10.1074/jbc.M112.362343
56. Lim J H, Y M Lee, Y S Chun, J Chen, J E Kim, J W Park: Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol Cell., 38(6), 864-878 (2010) DOI: 10.1016/j.molcel.2010.05.023
57. Nakamura Y, M Ogura, K Ogura, D Tanaka, N Inagaki: SIRT5 deacetylates and activates urate oxidase in liver mitochondria of mice. FEBS Lett, 586(23), 4076-4081 (2012) DOI: 10.1016/j.febslet.2012.10.009
58. Vassilopoulos A, J D Pennington, T Andresson, D M Rees, A D Bosley, I M Fearnley, A Ham, C R Flynn, S Hill, K L Rose, H S Kim, C X Deng, J E Walker, D Gius: SIRT3 Deacetylates ATP Synthase F1 Complex Proteins in Response to Nutrient- and Exercise-Induced Stress. Antioxid Redox Signal, 21(4):551-564 (2014) DOI: 10.1089/ars.2013.5420
59. He W, J C Newman, M Z Wang, L Ho, E Verdin: Mitochondrial sirtuins: regulators of protein acylation and metabolism. Trends Endocrinol Metab, 23(9),467-476 (2012) DOI: 10.1016/j.tem.2012.07.004
60. Hirschey M D, T Shimazu, J Y Huang, B Schwer, E Verdin: SIRT3 Regulates Mitochondrial Protein Acetylation and Intermediary Metabolism. Cold Spring Harb Symp Quant Biol, 76, 267-277 (2011) DOI: 10.1101/sqb.2011.76.010850
61. Nakagawa T, D J Lomb, M C Haigis, L Guarente: SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell, 137(3), 560-570 (2009) DOI: 10.1016/j.cell.2009.02.026
62. Nakagawa T, L Guarente: Urea cycle regulation by mitochondrial sirtuin, SIRT5. Aging (Albany NY), 1(6):578-581 (2009)
63. Hallows W C, W Yu, B C Smith, M K Devries, J J Ellinger, S Someya, M R Shortreed, T Prolla, J L Markley, L M Smith, S Zhao, K L Guan, J M Denu: Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction. Mol Cell, 41(2):139-149 (2011) DOI: 10.1016/j.molcel.2011.01.002
64. Schwer B, J Bunkenborg, R O Verdin, J S Andersen, E Verdin: Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc Natl Acad Sci, 103: 10224-10229 (2006) DOI: 10.1073/pnas.0603968103
65. Qiu X, K Brown, M D Hirschey, E Verdin, D Chen: Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab, 12, 662-667 (2010) DOI: 10.1016/j.cmet.2010.11.015
66. Hirschey M D, T Shimazu, E Jing, C A Grueter, A M Collins, B Aouizerat, A Stancakova, E Goetzman, M M Lam, B Schwer, R D Stevens, M J Muehlbauer, S Kakar, N M Bass, J Kuusisto, M Laakso, F W, C B Newgard, R V Farese Jr, C R Kahn, E Verdin: SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol Cell, 44, 177-190 (2011) DOI: 10.1016/j.molcel.2011.07.019
67. Bell E L, B M Emerling, S J Ricoult, L Guarente: SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production. Oncogene, 30, 2986-2996 (2011) DOI: 10.1038/onc.2011.37
68. Finley L W, A Carracedo, J Lee, A Souza, A Egia, J Zhang, J Teruya-Feldstein, P I Moreira, S M Cardoso, C B Clish, P P Pandolfi, M C Haigis: SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization. Cancer Cell, 19, 416-428 (2011) DOI: 10.1016/j.ccr.2011.02.014
69. Zhong L, A D'Urso, D Toiber, C Sebastian, R E Henry, D D Vadysirisack, A Guimaraes, B Marinelli, J D Wikstrom, T Nir, C B Clish, B Vaitheesvaran, O Iliopoulos, I Kurland, Y Dor, R Weissleder, O S Shirihai, L W Ellisen, J M Espinosa, R Mostoslavsky: The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1α. Cell, 140: 280-293 (2010) DOI: 10.1016/j.cell.2009.12.041
70. Haigis M C, R Mostoslavsky, K M Haigis, K Fahie, D C Christodoulou, A J Murphy, D M Valenzuela, G D Yancopoulos, M Karow, G Blander, C Wolberger, T A Prolla, R Weindruch, F W Alt, L Guarente: SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic β cells. Cell, 126, 941-954 (2006) DOI: 10.1016/j.cell.2006.06.057
71. Guarente L: The many faces of sirtuins: Sirtuins and the Warburg effect. Nat Med, 20(1), 24-25 (2014) DOI: 10.1038/nm.3438
72. Jeong S M, C Xiao, L W Finley, T Lahusen, A L Souza, K Pierce, Y H Li, X Wang, G Laurent, N J German, X Xu, C Li, R H Wang, J Lee, A Csibi, R Cerione, J Blenis, C B Clish, A Kimmelman, C X Deng, M C Haigis: SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism. Cancer Cell, 23, 450-463 (2013) DOI: 10.1016/j.ccr.2013.02.024
73. Sebastian C, B M Zwaans, D M Silberman, M Gymrek, A Goren, L Zhong, O Ram, J Truelove, A R Guimaraes, D Toiber, C Cosentino, J K Greenson, A I MacDonald, L McGlynn, F Maxwell, J Edwards, S Giacosa, E Guccione, R Weissleder, B E Bernstein, A Regev, P G Shiels, D B Lombard, R Mostoslavsky: The histone deacetylase SIRT6 is a tumor suppressor that controls metabolism. Cell, 15, 1185-1199 (2012) DOI: 10.1016/j.cell.2012.10.047
74. Csibi A, S M Fendt, C Li, G Poulogiannis, A Y Choo, D J Chapski, S M Jeong, J M Dempsey, A Parkhitko, T Morrison, E P Henske, M C Haigis, L C Cantley, G Stephanopoulos, J Yu, J Blenis: The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4. Cell, 153: 840-854 (2013) DOI: 10.1016/j.cell.2013.04.023
75. Firestein R, G Blander, S Michan, P Oberdoerffer, S Ogino, J Campbell, A Bhimavarapu, S Luikenhuis, R de Cabo, C Fuchs, W C Hahn, L P Guarente, D A Sinclair: The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS ONE, 3: e2020 (2008) DOI: 10.1371/journal.pone.0002020
76. Li H J, X M Che, W Zhao, S C He, Z L Zhang, R Chen, L Fan, Z L Jia: Dietinduced obesity promotes murine gastric cancer growth through a nampt/sirt1/cmyc positive feedback loop. Oncol Rep, 30(5),2153-2160 (2013)
77. Ristow M, K Schmeisser: Mitohormesis: Promoting Health and Lifespan by Increased Levels of Reactive Oxygen Species (ROS). Dose Response, 12(2), 288-341 (2014) DOI: 10.2203/dose-response.13-035.Ristow
78. Hubbard B P, A P Gomes, H Dai, J Li, A W Case, T Considine, T V Riera, J E Lee, E SY, D W Lamming, B L Pentelute, E R Schuman, L A Stevens, A J Ling, S M Armour, S Michan, H Zhao, Y Jiang, S M Sweitzer, C A Blum, J S Disch, P Y Ng, K T Howitz, A P Rolo, Y Hamuro, J Moss, R B Perni, J L Ellis, G P Vlasuk, D A Sinclair: Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science, 339, 1216-1219 (2013) DOI: 10.1126/science.1231097
79. Fiorino E, M Giudici, A Ferrari, N Mitro, D Caruso, E De Fabiani, M Crestani: The sirtuin class of histone deacetylases: regulation and roles in lipid metabolism. IUBMB Life, 66(2), 89-99 (2014) DOI: 10.1002/iub.1246
80. Kleine H, E Poreba, K Lesniewicz, P O Hassa, M O Hottiger, D W Litchfield, B H Shilton, B Lüscher: Substrate-assisted catalysis by PARP10 limits its activity to mono-ADP-ribosylation. Mol Cell, 32(1), 57-69. (2008) DOI: 10.1016/j.molcel.2008.08.009
81. Hottiger M O, P O Hassa, B Lüscher, H Schüler, F Koch-Nolte: Toward a unified nomenclature for mammalian ADPribosyltransferases. Trends Biochem Sci, 35(4):208-19 (2010) DOI: 10.1016/j.tibs.2009.12.003
82. Schreiber V, F Dantzer, J C Ame, G de Murcia: Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol, 7, 517-528 (2006) DOI: 10.1038/nrm1963
83. Hsiao J, S Smith: Tankyrase function at telomeres, spindle poles, and beyond. Biochimie, 90(1), 83-92 (2008) DOI: 10.1016/j.biochi.2007.07.012
84. De Maio A, E Natale, S Rotondo, A Di Cosmo, M R Faraone-Mennella: Vault-poly-ADP-ribose polymerase in the Octopus vulgaris brain: A regulatory factor of actin polymerization dynamic. Comp Biochem Phys - Part B, 166(1), 40-47 (2013) DOI: 10.1016/j.cbpb.2013.06.007
85. Till S, K Diamantara, A G Ladurner: PARP: a transferase by any other name. Nat Struct Mol Biol, 15, 1243-1244 (2008) DOI: 10.1038/nsmb1208-1243
86. Germain M, E B Affar, D D'Amours, V M Dixit, G S Salvesen, G G Poirier: Cleavage of Automodified Poly(ADPribose) Polymerase during Apoptosis. J Biol Chem, 274, 28379-28384 (1999) DOI: 10.1074/jbc.274.40.28379
87. Kim M Y, T Zhang, W L Kraus: Poly(ADPribosyl) ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal. Genes & Dev, 19, 1951-1967 (2005) DOI: 10.1101/gad.1331805
88. Jankevicius G, M Hassler, B Golia, V Rybin, M Zacharias, G Timinszky, A G Ladurner: A family of macrodomain proteins reverses cellular mono-ADPribosylation. Nat Struct Mol Biol, 20,508-514 (2013) DOI: 10.1038/nsmb.2523
89. Weaver A N, E S Yang: Beyond DNA Repair: Additional Functions of PARP-1 in Cancer. Front Oncol, 3, 290. eCollection 2013
90. Caldecott K W: Protein ADP-ribosylation and the cellular response to DNA strand breaks. DNA Repair (Amst), 19:108-113 (2014) DOI: 10.1016/j.dnarep.2014.03.021
91. Morales J, L Li, F J Fattah, Y Dong, E A Bey, M Patel, J Gao, D A Boothman: Review of poly (ADP-ribose) polymerase (PARP) mechanisms of action and rationale for targeting in cancer and other diseases. Crit Rev Eukaryot Gene Expr, 24(1),15-28 (2014) DOI: 10.1615/CritRevEukaryotGeneExpr.2013006875
92. Schreiber V, J C Ame, P Dolle, I Schultz, B Rinaldi, V Fraulob, J Menissier-de Murcia, G de Murcia: Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1. J Biol Chem, 277(25), 23028-23036 (2002) DOI: 10.1074/jbc.M202390200
93. Yelamos J, J Farres, L Llacuna, C Ampurdanes, J Martin-Caballero: PARP-1 and PARP-2: New players in tumour development. Am J Cancer Res, 1(3), 328-346 (2011)
94. Kutuzov M M, S N Khodyreva, J C Amé, E S Ilina, M V Sukhanova, V Schreiber, O I Lavrik: Interaction of PARP-2 with DNA structures mimicking DNA repair intermediates and consequences on activity of base excision repair proteins. Biochimie, 95(6),1208-1215 (2013) DOI: 10.1016/j.biochi.2013.01.007
95. Cohausz O, F R Althaus: Role of PARP-1 and PARP-2 in the expression of apoptosis-regulating genes in HeLa cells. Cell Biol Toxicol, 25(4), 379-391 (2008) DOI: 10.1007/s10565-008-9092-8
96. Szántó M, A Brunyánszki, B Kiss, L Nagy, P Gergely, L Virág, P Bai: Poly(ADP-ribose) polymerase-2: emerging transcriptional roles of a DNA-repair protein. Cell Mol Life Sci, 69(24), 4079-4092 (2012) DOI: 10.1007/s00018-012-1003-8
97. Bhute V, D Beard, S Kron, S Palecek: Nuclear magnetic resonance based targeted profiling of metabolic responses induced by DNA damaging agents and PARP inhibition in MCF-7 cells. Cancer & Metabolism, 2(Suppl 1):P8 (2014) DOI: 10.1.186/2049-3002-2-S1-P8
98. Altmeyer M, M O Hottiger: Poly(ADPribose) polymerase 1 at the crossroad of metabolic stress and inflammation in aging. AGING, 1(5), 458-469 (2009)
99. Luo X, W L Kraus:, A One and a Two ... Expanding Roles for Poly(ADPRibose) Polymerases in Metabolism Cell Metabolism, 13(4), 353-355 (2011) DOI: 10.1016/j.cmet.2011.03.011
100. Luo X, W L Kraus: On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1. Genes & Dev, 26, 417-432 (2012) DOI: 10.1101/gad.183509.111
101. Bai P, C Cantó: The Role of PARP-1 and PARP-2 Enzymes in Metabolic Regulation and Disease. Cell metabolism, 16(3), 290-295 (2012)
102. Wellen K E, C B Thompson : Cellular metabolic stress: considering how cells respond to nutrient excess. Mol Cell, 40(2), 323-332 (2010) DOI: 10.1016/j.molcel.2010.10.004
103. Erener S, M Hesse, R Kostadinova, M O Hottiger: Poly(ADP-ribose)polymerase-1 (PARP1) controls adipogenic gene expression and adipocyte function. Mol Endocrinol, 26(1), 79-86 (2011) DOI: 10.1210/me.2011-1163
104. Mansour M: The roles of peroxisome proliferator-activated receptors in the metabolic syndrome. Prog Mol Biol Transl Sci, 121:217-66 (2014) DOI: 10.1016/B978-0-12-800101-1.00007-7
105. Cantó C, J Auwerx: Interference between PARPs and SIRT1: a novel approach to healthy ageing?. Aging, 3(5), 543-547 (2011)
106. Berger N A: Poly(ADP-ribose) in the cellular response to DNA damage. Radiat Res, 101, 4-15 (1985) DOI: 10.2307/3576299
107. Houtkooper R H, C Canto, R J Wanders, J Auwerx: The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. Endocr Rev, 31, 194-223 (2010) DOI: 10.1210/er.2009-0026
108. Bitterman K J, R M Anderson, H Y Cohen, M Latorre-Esteves, D A Sinclair: Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J Biol Chem, 277, 45099-45107 (2002) DOI: 10.1074/jbc.M205670200
109. Rajamohan S B, V B Pillai, M Gupta, N R Sundaresan, K G Birukov, S Samant, MO Hottiger, MP Gupta : SIRT1 promotes cell survival under stress by deacetylationdependent deactivation of poly(ADPribose) polymerase 1. Mol Cell Biol, 29, 4116-4129 (2009) DOI: 10.1128/MCB.00121-09
110. Cantó C, A A Sauve, P Bai: Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes. Mol Aspects Med, 34(6), 1168-201 (2013) DOI: 10.1016/j.mam.2013.01.004
111. Bai P, C Canto, A Brunyánszki, A Huber, M Szántó Y Cen, H Yamamoto, S M Houten, B Kiss, H Oudart, P Gergely, J Menissier-de Murcia, V Schreiber, A A Sauve, J Auwerx: PARP-2 regulates SIRT1 expression and whole-body energy expenditure. Cell Metab, 13(4), 450-60 (2011) DOI: 10.1016/j.cmet.2011.03.013
112. Houtkooper R H, J Auwerx: Exploring the therapeutic space around NAD+. J Cell Biol, 199 (2), 205-209 (2012) DOI: 10.1083/jcb.201207019
113. Szántó M, I Rutkai, C Hegedus, A Czikora, M Rózsahegyi, B Kiss, L Virág, P Gergely, A Tóth, P Bai: Poly(ADPribose) polymerase-2 depletion reduces doxorubicin-induced damage through SIRT1 induction. Cardiovasc Res, 92(3):430-4388 (2011) DOI: 10.1093/cvr/cvr246
114. Bai P, S M Houten, A Huber, V Schreiber, M Watanabe, B Kiss, G de Murcia, J Auwerx, J Ménissier-de Murcia: Poly(ADP-ribose) polymerase-2 controls adipocyte differentiation and adipose tissue function through the regulation of the activity of the retinoid X receptor/peroxisome proliferator-activated receptor-gamma heterodimer. J Biol Chem, 282(52), 37738-37746 (2007) DOI: 10.1074/jbc.M701021200
115. Yang H, T Yang, J A Baur, E. Perez, T Matsui, J J Carmona, D W Lamming, N C Souza-Pinto, V A Bohr, A Rosenzweig, R de Cabo, A A Sauve, D A Sinclair: Nutrient-Sensitive Mitochondrial NAD+ Levels Dictate Cell Survival. Cell, 130 (6), 1095-1107 (2007) DOI: 10.1016/j.cell.2007.07.035
116. Marcheva B, K M Ramsey, C B Peek, A Affinati, E Maury, J Bass: Circadian clocks and metabolism. Handb Experim Pharmacol, 217, 127-155 (2013) DOI: 10.1007/978-3-642-25950-0-6
117. Crane B R, M W Young: Interactive Features of Proteins Composing Eukaryotic Circadian Clocks. Annu Rev Biochem, 83, 191-219 (2014) DOI: 10.1146/annurev-biochem-060713-035644
118. Cantó C, J Auwerx: Targeting Sirtuin 1 to Improve Metabolism: All You Need Is NAD+?. Pharmacological Reviews, 64 (1), 166-187 (2012) DOI: 10.1124/pr.110.003905
119. Van Meter M, Z Mao, V Gorbunova, A Seluanov: Repairing split ends: SIRT6, mono-ADP ribosylation and DNA repair. AGING, 3(9), 829-835 (2011)
120. Mao Z, C Hine, X Tian, M Van Meter, M Au, A Vaidya, A Seluanov, V Gorbunova: SIRT6 promotes DNA repair under stress by activating PARP1. Science, 332, 1443-1446 (2011) DOI: 10.1126/science.1202723
121. Tennen R I, D J Bua, W E Wright, K F Chua: SIRT6 is required for maintenance of telomere position effect in human cells. Nat Commun, 2, 433 (2011) DOI: 10.1038/ncomms1443
122. Cosentino C, R Mostoslavsky: Metabolism, Longevity and Epigenetics. Cell Mol Life Sci, 70(9), 1525-1541 (2013) DOI: 10.1007/s00018-013-1295-3
123. Braidy N, G J Guillemin, H Mansour, T Chan-Ling, A Poljak, R Grant: Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats. PLoS One, 6(4), e19194 (2011) DOI: 10.1371/journal.pone.0019194